Video content above is prompted by the following questions: What barriers prevent the uptake of RSV vaccines? How can these barriers be addressed and vaccine uptake be improved by pharmacists? What types of preventative measures (i.e. additional vaccines, expanded indications or populations) are in the pipeline for RSV?